CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 71.43%

Compliant submissions 5

Incompliant submissions 2

Total trials 7

My Organizations' Clinical Trials

Showing 650 of 1097 entries

View as:

Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women

Phase: N/A Priority: Normal

NCT ID: NCT01501084 Org: User:

Start: 12/31/11 End: 02/28/13 Due: 02/28/14

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Phase: N/A Priority: Normal

NCT ID: NCT04344626 Org: User:

Start: 07/16/18 End: 03/31/23 Due: 03/31/24

Management of Diabetes With Metformin In Patients With Chronic Heart Failure

Phase: N/A Priority: Normal

NCT ID: NCT01122316 Org: User:

Start: 09/30/09 End: 01/31/12 Due: 01/31/13

Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II

Phase: N/A Priority: Normal

NCT ID: NCT02317250 Org: User:

Start: 06/30/18 End: 12/31/22 Due: 12/31/23

Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID

Phase: N/A Priority: Normal

NCT ID: NCT02999984 Org: User:

Start: 12/16/16 End: 09/26/19 Due: 09/26/20

Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients

Phase: N/A Priority: Normal

NCT ID: NCT04937868 Org: User:

Start: 01/15/18 End: 06/15/26 Due: 06/15/27

Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke Before and After Thrombectomy

Phase: N/A Priority: Normal

NCT ID: NCT04061577 Org: User:

Start: 07/28/19 End: 04/01/22 Due: 04/01/23

Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients

Phase: N/A Priority: Normal

NCT ID: NCT04997473 Org: User:

Start: 08/15/21 End: 01/09/26 Due: 01/09/27

Revefenacin in Acute Respiratory Insufficiency in COPD

Phase: N/A Priority: Normal

NCT ID: NCT04315558 Org: User:

Start: 11/01/20 End: 06/30/25 Due: 06/30/26

N-Acetyl Cysteine Protects Pulpal Stem Cells in Endodontic Revascularization

Phase: N/A Priority: Normal

NCT ID: NCT03451435 Org: User:

Start: 06/15/18 End: 06/15/20 Due: 06/15/21

Decreasing Intraoperative Skin Damage in Prone Position Surgeries

Phase: N/A Priority: Normal

NCT ID: NCT04884737 Org: User:

Start: 07/02/21 End: 03/10/23 Due: 03/10/24

Stigma Among Women With HIV in Vietnam

Phase: N/A Priority: Normal

NCT ID: NCT05357118 Org: User:

Start: 09/30/23 End: 05/18/24 Due: 05/18/25

Improving Older Adults' Decision Making for OSAT

Phase: N/A Priority: Normal

NCT ID: NCT03138993 Org: User:

Start: 05/22/17 End: 11/30/18 Due: 11/30/19

Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy

Phase: N/A Priority: Normal

NCT ID: NCT02003183 Org: User:

Start: 03/31/13 End: 12/31/18 Due: 12/31/19

Electronic Hookah and Endothelial Cell Function

Phase: N/A Priority: Normal

NCT ID: NCT04133376 Org: User:

Start: 11/01/19 End: 05/29/23 Due: 05/29/24

BiNational Quit Using Drugs Intervention Trial

Phase: N/A Priority: Normal

NCT ID: NCT01942811 Org: User:

Start: 02/28/13 End: 02/28/14 Due: 02/28/15

A Study of Meditation as a Treatment for Epilepsy

Phase: N/A Priority: Normal

NCT ID: NCT00370929 Org: User:

Start: 05/31/06 End: 01/31/08 Due: 01/31/09

Celecoxib in Preventing Lung Cancer in Former Heavy Smokers

Phase: N/A Priority: Normal

NCT ID: NCT00055978 Org: User:

Start: 10/31/02 End: 05/31/09 Due: 05/31/10

Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6

Phase: N/A Priority: Normal

NCT ID: NCT00000303 Org: User:

Start: 10/31/97 End: - Due: -

Clinical Rescue Protocol - 2

Phase: N/A Priority: Normal

NCT ID: NCT00000206 Org: User:

Start: 04/30/91 End: - Due: -

Multicenter Clinical Trial of Buprenorphine - 3

Phase: N/A Priority: Normal

NCT ID: NCT00000207 Org: User:

Start: 05/31/92 End: - Due: -

Feasibility Study of Take-Home LAAM Medication - 3

Phase: N/A Priority: Normal

NCT ID: NCT00000300 Org: User:

Start: 03/31/95 End: - Due: -

Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4

Phase: N/A Priority: Normal

NCT ID: NCT00000301 Org: User:

Start: 03/31/96 End: - Due: -

Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2

Phase: N/A Priority: Normal

NCT ID: NCT00000299 Org: User:

Start: 10/31/08 End: 11/30/09 Due: 11/30/10

Buprenorphine Maintenance Protocol - 1

Phase: N/A Priority: Normal

NCT ID: NCT00000205 Org: User:

Start: 10/31/90 End: 09/30/93 Due: 09/30/94

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women	NCT01501084	University of California, Los Angeles	user2@example.com	None	2011-12-31	2013-02-28	2014-02-28	-	-	2025-07-14
Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery	NCT04344626	University of California, Los Angeles	user2@example.com	None	2018-07-16	2023-03-31	2024-03-31	-	-	2025-07-14
Management of Diabetes With Metformin In Patients With Chronic Heart Failure	NCT01122316	University of California, Los Angeles	user2@example.com	None	2009-09-30	2012-01-31	2013-01-31	-	-	2025-07-14
Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II	NCT02317250	University of California, Los Angeles	user2@example.com	None	2018-06-30	2022-12-31	2023-12-31	-	-	2025-07-14
Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID	NCT02999984	University of California, Los Angeles	user2@example.com	None	2016-12-16	2019-09-26	2020-09-26	-	-	2025-07-14
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients	NCT04937868	University of California, Los Angeles	user2@example.com	None	2018-01-15	2026-06-15	2027-06-15	-	-	2025-07-14
Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke Before and After Thrombectomy	NCT04061577	University of California, Los Angeles	user2@example.com	None	2019-07-28	2022-04-01	2023-04-01	-	-	2025-07-14
Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients	NCT04997473	University of California, Los Angeles	user2@example.com	None	2021-08-15	2026-01-09	2027-01-09	-	-	2025-07-14
Revefenacin in Acute Respiratory Insufficiency in COPD	NCT04315558	University of California, Los Angeles	user2@example.com	None	2020-11-01	2025-06-30	2026-06-30	-	-	2025-07-14
N-Acetyl Cysteine Protects Pulpal Stem Cells in Endodontic Revascularization	NCT03451435	University of California, Los Angeles	user2@example.com	None	2018-06-15	2020-06-15	2021-06-15	-	-	2025-07-14
Decreasing Intraoperative Skin Damage in Prone Position Surgeries	NCT04884737	University of California, Los Angeles	user2@example.com	None	2021-07-02	2023-03-10	2024-03-10	-	-	2025-07-14
Stigma Among Women With HIV in Vietnam	NCT05357118	University of California, Los Angeles	user2@example.com	None	2023-09-30	2024-05-18	2025-05-18	-	-	2025-07-14
Improving Older Adults' Decision Making for OSAT	NCT03138993	University of California, Los Angeles	user2@example.com	None	2017-05-22	2018-11-30	2019-11-30	-	-	2025-07-14
Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy	NCT02003183	University of California, Los Angeles	user2@example.com	None	2013-03-31	2018-12-31	2019-12-31	-	-	2025-07-14
Electronic Hookah and Endothelial Cell Function	NCT04133376	University of California, Los Angeles	user2@example.com	None	2019-11-01	2023-05-29	2024-05-29	-	-	2025-07-14
BiNational Quit Using Drugs Intervention Trial	NCT01942811	University of California, Los Angeles	user2@example.com	None	2013-02-28	2014-02-28	2015-02-28	-	-	2025-07-14
A Study of Meditation as a Treatment for Epilepsy	NCT00370929	University of California, Los Angeles	user2@example.com	None	2006-05-31	2008-01-31	2009-01-31	-	-	2025-07-14
Celecoxib in Preventing Lung Cancer in Former Heavy Smokers	NCT00055978	University of California, Los Angeles	user2@example.com	None	2002-10-31	2009-05-31	2010-05-31	-	-	2025-07-14
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6	NCT00000303	University of California, Los Angeles	user4@example.com	Incompliant	1997-10-31	-	-	2025-07-01	-	2025-07-14
Clinical Rescue Protocol - 2	NCT00000206	University of California, Los Angeles	user7@example.com	Compliant	1991-04-30	-	-	2025-07-01	-	2025-07-14
Multicenter Clinical Trial of Buprenorphine - 3	NCT00000207	University of California, Los Angeles	user8@example.com	Compliant	1992-05-31	-	-	2025-07-01	-	2025-07-14
Feasibility Study of Take-Home LAAM Medication - 3	NCT00000300	University of California, Los Angeles	user1@example.com	Compliant	1995-03-31	-	-	2025-07-01	-	2025-07-14
Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4	NCT00000301	University of California, Los Angeles	user2@example.com	Incompliant	1996-03-31	-	-	2025-07-01	-	2025-07-14
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2	NCT00000299	University of California, Los Angeles	user10@example.com	Compliant	2008-10-31	2009-11-30	2010-11-30	2025-07-01	-	2025-07-14
Buprenorphine Maintenance Protocol - 1	NCT00000205	University of California, Los Angeles	user6@example.com	Compliant	1990-10-31	1993-09-30	1994-09-30	2025-07-01	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance